AGP Executive Report
Last update: 5 minutes agoAutoimmune After COVID: A new review of eight large studies (including Germany) links COVID-19 to a higher risk of developing new autoimmune diseases afterward, with adjusted risk increases reported across many body systems—though the absolute risk for any one condition stays low. Hidradenitis Breakthrough: German researchers report povorcitinib (a JAK1 inhibitor) rapidly improves moderate-to-severe hidradenitis suppurativa in two phase 3 trials, with about 40–42% reaching key response targets versus 30% on placebo. Emergency Care Pressure: A study ties emergency department overcrowding and “corridor care” to higher patient mortality, adding to calls for staffing and flow fixes. Forensic MRI for Legal Age: German researchers test a more detailed MRI staging approach for knee growth plates to estimate age in cases involving undocumented young people, showing it’s feasible but limited for key legal thresholds. Digital Health & Privacy: Reports highlight ongoing concerns about AI “agent” activity and leaked user images, underscoring privacy and oversight gaps. Workforce & Care Access: A major German pharma cold-store expansion (Movianto) points to growing logistics capacity for medicines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
